183 related articles for article (PubMed ID: 27655905)
21. The survival impact of preoperative FOLFOX for resectable locally advanced rectal cancer: the R-NAC-01 study.
Ichikawa N; Homma S; Funakoshi T; Hattori M; Sato M; Kamiizumi Y; Omori K; Nomura M; Yokota R; Koike M; Kon H; Takeda K; Ishizu H; Matsuoka S; Hirose K; Ishikawa T; Murata R; Iijima H; Yoshida T; Minagawa N; Takahashi N; Taketomi A
Surg Today; 2022 Aug; 52(8):1134-1142. PubMed ID: 34985549
[TBL] [Abstract][Full Text] [Related]
22. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Chakravarthy AB; Zhao F; Meropol NJ; Flynn PJ; Wagner LI; Sloan J; Diasio RB; Mitchell EP; Catalano P; Giantonio BJ; Catalano RB; Haller DG; Awan RA; Mulcahy MF; O'Brien TE; Santala R; Cripps C; Weis JR; Atkins JN; Leichman CG; Petrelli NJ; Sinicrope FA; Brierley JD; Tepper JE; O'Dwyer PJ; Sigurdson ER; Hamilton SR; Cella D; Benson AB
Oncologist; 2020 May; 25(5):e798-e807. PubMed ID: 31852811
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
Koike J; Funahashi K; Yoshimatsu K; Yokomizo H; Kan H; Yamada T; Ishida H; Ishibashi K; Saida Y; Enomoto T; Katsumata K; Hisada M; Hasegawa H; Koda K; Ochiai T; Sakamoto K; Shiokawa H; Ogawa S; Itabashi M; Kameoka S
Cancer Chemother Pharmacol; 2017 Mar; 79(3):519-525. PubMed ID: 28150022
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study).
Moritani K; Kanemitsu Y; Shida D; Shitara K; Mizusawa J; Katayama H; Hamaguchi T; Shimada Y;
Jpn J Clin Oncol; 2020 Jan; 50(1):89-93. PubMed ID: 31829404
[TBL] [Abstract][Full Text] [Related]
25. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
[TBL] [Abstract][Full Text] [Related]
26. A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis.
Ohue M; Hamaguchi T; Ito Y; Sakai D; Noura S; Kinugasa Y; Fujita S; Shimada Y; Saito N; Moriya Y
Int J Clin Oncol; 2015 Apr; 20(2):338-44. PubMed ID: 24839048
[TBL] [Abstract][Full Text] [Related]
27. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
Katz MHG; Ou FS; Herman JM; Ahmad SA; Wolpin B; Marsh R; Behr S; Shi Q; Chuong M; Schwartz LH; Frankel W; Collisson E; Koay EJ; Hubbard JM; Leenstra JL; Meyerhardt J; O'Reilly E;
BMC Cancer; 2017 Jul; 17(1):505. PubMed ID: 28750659
[TBL] [Abstract][Full Text] [Related]
28. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
[TBL] [Abstract][Full Text] [Related]
29. Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).
Watari H; Katayama H; Shibata T; Ushijima K; Satoh T; Onda T; Aoki D; Fukuda H; Yaegashi N; Sakuragi N;
Jpn J Clin Oncol; 2017 Oct; 47(10):986-990. PubMed ID: 28981739
[TBL] [Abstract][Full Text] [Related]
30. Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Fischer von Weikersthal L; Schalhorn A; Stauch M; Quietzsch D; Maubach PA; Lambertz H; Oruzio D; Schlag R; Weigang-Köhler K; Vehling-Kaiser U; Schulze M; Truckenbrodt J; Goebeler M; Mittermüller J; Bosse D; Szukics B; Grundeis M; Zwingers T; Giessen C; Heinemann V
Eur J Cancer; 2011 Jan; 47(2):206-14. PubMed ID: 20971632
[TBL] [Abstract][Full Text] [Related]
31. [A case of neoadjuvant chemotherapy for locally advanced rectal cancer, which had a invasion into the vagina followed by curative resection].
Kimura K; Kagawa Y; Kato T; Ishida T; Morimoto Y; Matusita K; Kusama H; Hashimoto T; Katura Y; Nitta K; Takeno A; Nakahira S; Okishiro M; Sakisaka H; Taniguchi H; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1740-2. PubMed ID: 25731314
[TBL] [Abstract][Full Text] [Related]
32. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
[TBL] [Abstract][Full Text] [Related]
33. Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study.
Kamiya T; Uehara K; Nakayama G; Ishigure K; Kobayashi S; Hiramatsu K; Nakayama H; Yamashita K; Sakamoto E; Tojima Y; Kawai S; Kodera Y; Nagino M;
Eur J Surg Oncol; 2016 Jun; 42(6):829-35. PubMed ID: 26968228
[TBL] [Abstract][Full Text] [Related]
34. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis.
Kim KH; Shin SJ; Cho MS; Ahn JB; Jung M; Kim TI; Park YS; Kim H; Kim NK; Koom WS
Radiother Oncol; 2016 Feb; 118(2):369-74. PubMed ID: 26705682
[TBL] [Abstract][Full Text] [Related]
36. Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study.
Hildebrandt B; Wust P; Dräger J; Lüdemann L; Sreenivasa G; Tullius SG; Amthauer H; Neuhaus P; Felix R; Riess H
Int J Hyperthermia; 2004 Jun; 20(4):359-69. PubMed ID: 15204518
[TBL] [Abstract][Full Text] [Related]
37. Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial.
Oki E; Shimokawa M; Ando K; Murata A; Takahashi T; Maeda K; Kusumoto T; Munemoto Y; Nakanishi R; Nakashima Y; Saeki H; Maehara Y
Surgery; 2019 Mar; 165(3):586-592. PubMed ID: 30314724
[TBL] [Abstract][Full Text] [Related]
38. Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance).
Schrag D; Weiser M; Saltz L; Mamon H; Gollub M; Basch E; Venook A; Shi Q
Clin Trials; 2019 Apr; 16(2):165-175. PubMed ID: 30688523
[TBL] [Abstract][Full Text] [Related]
39. A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
Toritani K; Watanabe J; Suwa Y; Nakagawa K; Suwa H; Ishibe A; Ota M; Kunisaki C; Yamanaka T; Endo I
Int J Colorectal Dis; 2020 Dec; 35(12):2197-2204. PubMed ID: 32725346
[TBL] [Abstract][Full Text] [Related]
40. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
